Although silencing of METTL3 did not dramatically affect the steady state mRNA levels, differences in gene expression (DEG) were more exacerbated in the breast cancer cell lines compared to MCF10-A cells (Fig. 2O–Q; Supplementary Fig. 2M; Supplementary Table S3). Here, METTL3 is linked to breast carcinoma.